To identify whether c-MET addiction of 4T1 tumor cells and their concomitant sensitivity to c-MET blockade could explain the reduction in cell proliferation upon OMO-1 treatment, we evaluated c-MET expression in 4T1 primary tumors. The gene discussed is MET; the disease is neoplasm.